EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Criteria for evaluation of response to biologics in severe asthma – the Biologics Asthma Response Score (BARS)

Katrin Milger, Stephanie Korn, Claudia Feder, Jan Fuge, Andreas Mühle, Wolfgang Schütte, Dirk Skowasch, Hartmut Timmermann, Hendrik Suhling

Pneumologie · 01.06.2025 · 79 (06) · 439-451

DOI: 10.1055/a-2102-8128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pneumologie, erschienen am 01.06.2025. Verfasst von Katrin Milger und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medizinische Klinik und Poliklinik V, LMU Klinikum, München, Comprehensive Pneumology Center (CPC-M), Mitglied des Deutschen Zentrums für Lungenforsc…. Hauptthemen laut MEDLINE: Asthma, Biological Products, Anti-Asthmatic Agents, Severity of Illness Index. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The introduction of monoclonal antibodies (biologics) has revolutionized the therapy of severe asthma. Even though there is a response in the majority of patients, the degree of response varies. To date criteria for assessment of response to biologics are not consistently defined.

Aim

To define criteria for evaluation of response to biologics that are precise, simple and suitable for daily use in order to guide decision-making regarding continuation, switching or stopping of biological therapy.

Methods

8 physicians with large experience in this indication, supported by a data-scientist, developed a consensus on criteria to evaluate response to biologics in patients with severe asthma.

Result

We developed a combined score based on current literature, own experience and practicability. It uses the main criteria exacerbations, oral corticosteroid (OCS) therapy and asthma control (asthma control test, ACT). We defined thresholds for “good response”, “response” and “insufficient response” rated with a score of “2”, “1” and “0” respectively: annual exacerbations (“0 or reduction ≥ 75 %”, “reduction 50–74 %”, “reductio < 50 %”), daily OCS dose (“stopping or reduction ≥ 75 %”, “reduction 50–74 %”, “reduction < 50 %”), asthma control (“ACT increase ≥ 6 or ≥ 3 with result ≥ 20”, “ACT increase 3–5 with result < 20”, “ACT increase < 3”). Additional individual criteria like lung function and comorbidities may be important for evaluation of response. We propose 3, 6 and 12 months timepoint for assessment of tolerability and response. Using the combined score, we developed a scheme to guide the decision whether switching the biologic should be considered.

Conclusion

The Biologic Asthma Response Score (BARS) serves as objective and simple tool to evaluate response to biologic therapy using the three main criteria exacerbations, OCS use and asthma control. A validation of the score was initiated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaBiological ProductsAnti-Asthmatic AgentsSeverity of Illness IndexOutcome Assessment, Health CareHumansTreatment OutcomeGermanyReproducibility of Results

Substanzen

Biological ProductsAnti-Asthmatic Agents

Autor:innen und Institutionen

  • Medizinische Klinik und Poliklinik V, LMU Klinikum, München, Comprehensive Pneumology Center (CPC-M), Mitglied des Deutschen Zentrums für Lungenforschung (DZL).
  • Institut für Klinische Forschung, Mainz.
  • Thoraxklinik, Universitätsklinikum Heidelberg.
  • Klinik für Innere Medizin V, Universitätsklinikum Jena.
  • Deutsches Zentrum für Lungenforschung, Standort Hannover.
  • Pneumologisches Facharztzentrum Teuchern.

Zitieren

APA

Milger, K., Korn, S., Feder, C., Fuge, J., Mühle, A., Schütte, W., Skowasch, D., Timmermann, H., & Suhling, H. (2025). Criteria for evaluation of response to biologics in severe asthma – the Biologics Asthma Response Score (BARS). Pneumologie, 79(06), 439-451. https://doi.org/10.1055/a-2102-8128

Vancouver

Milger K, Korn S, Feder C, Fuge J, Mühle A, Schütte W, et al. Criteria for evaluation of response to biologics in severe asthma – the Biologics Asthma Response Score (BARS). Pneumologie. 2025;79(06):439-451. doi:10.1055/a-2102-8128

BibTeX
@article{Milger2025,
  author = {Milger, Katrin and Korn, Stephanie and Feder, Claudia and Fuge, Jan and Mühle, Andreas and Schütte, Wolfgang and Skowasch, Dirk and Timmermann, Hartmut and Suhling, Hendrik},
  title = {Criteria for evaluation of response to biologics in severe asthma – the Biologics Asthma Response Score (BARS)},
  journal = {Pneumologie},
  year = {2025},
  volume = {79},
  number = {06},
  pages = {439--451},
  doi = {10.1055/a-2102-8128}
}
Kostenlos starten →